In a February 2024 article for Managed Health Care Executive 3 , Lassen states, Our chief concern with these drugs right now is how do we best manage the waste, because theres a real potential if people in real-world practice are not staying on these medications, then they are not going to do anything but promote cost and temporary weight loss, he says
however, because the greatest contributor to MASH is obesity, I believe this is more a function of weight loss than a direct effect of the medication
For instance, liposomal carriers have been developed to encapsulate exenatide and liraglutide, demonstrating improved stability and sustained release upon subcutaneous or intranasal administration
The psychological impact of seeing developing definition provides powerful motivation during the challenging middle months of treatment
For laboratory use, the powder is typically reconstituted with a suitable sterile diluent to a target working concentration